INOVIO PHARMACEUTICALS, INC. — Form D
INOVIO PHARMACEUTICALS, INC. of Plymouth Meeting, PA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-24. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-24
- Form: D
- Accession: 0001055726-20-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Investors: 1
- Date of first sale: 2019-12-31
- Security types: debt
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-358860
Issuer
- Name: INOVIO PHARMACEUTICALS, INC.
- CIK: 0001055726
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 660 W. Germantown Pike, Plymouth Meeting, PA, 19462
- Phone: 2674404200
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Simon X Benito | Director | Plymouth Meeting, PA |
| Angel X Cabrera | Director | Plymouth Meeting, PA |
| J. Jospeh Kim | Director | Plymouth Meeting, PA |
| Ann C Miller | Director | Newton, MA |
| Jay X Shepard | Director | Plymouth Meeting, PA |
| David B Weiner | Director | Plymouth Meeting, PA |
| Wendy L Yarno | Director | Charlottesville, VA |
| Lota S Zoth | Director | La Jolla, CA |
| Laurent S Humeau | Executive Officer | Plymouth Meeting, PA |
| Peter Jospeh Kies | Executive Officer | Plymouth Meeting, PA |
| J. Jospeh Kim | Executive Officer | Plymouth Meeting, PA |
| Jacqueline S Shea | Executive Officer | Plymouth Meeting, PA |
| Morton X Collins | Director | Plymouth Meeting, PA |
Other filings by this issuer (1)
More